---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047182"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T20:42:26.980069+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Hepion Pharma receives Nasdaq delisting notice due to stockholder deficit and failure to meet listing alternatives

## Summary
- Stockholders' deficit of ($406,685) as of Sept 30, 2024 triggers Nasdaq Listing Rule non-compliance.
- Company fails to meet alternatives: $35M market value or $500K net income in recent fiscal years.
- Nasdaq gives 45 days to submit a compliance plan; extension of up to 180 days possible.
- Common stock (HEPA) continues trading on Nasdaq Capital Market while cure process is pending.
- No assurance that listing will be maintained; potential for hearing panel appeal if plan rejected.

## SEC filing metadata
- accession: 0001493152-24-047182
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315224047182/0001493152-24-047182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315224047182/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047182
- JSON: https://secwatch.observer/filing/0001493152-24-047182.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047182.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.